ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Phenotypic Personalized Medicine: Mechanism-Independent Convergence Into Target Serum Tacrolimus Levels for Optimized Liver Transplant Immunosuppression

A. Zarrinpar,1 A. Silva,2 D.-K. Lee,3 N. Datta,1 C.-M. Ho,2 D. Ho.3

1Surgery-Division of Liver and Pancreas Transplantation, UCLA, Los Angeles, CA
2Mechanical Engineering, UCLA, Los Angeles, CA
3Bioengineering, and Oral Biology and Medicine, UCLA, Los Angeles, CA.

Meeting: 2015 American Transplant Congress

Abstract number: C264

Keywords: Dosage, FK506, Immunosuppression, Prediction models

Session Information

Session Name: Poster Session C: Translational Biomarkers and Immune Monitoring

Session Type: Poster Session

Date: Monday, May 4, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

PURPOSE:

Immunosuppressive drugs such as tacrolimus have narrow therapeutic ranges and their dosing variability necessitates intensive drug monitoring. This study aimed to use Feedback System Control (FSC), a mechanism-independent personalized medicine platform that rationally reconciles phenotypic responses to therapeutic intervention, to prescribe patient-specific drug regimens with rapid convergence towards target serum levels (1, 2).

MATERIALS & METHODS:

We retrospectively collected tacrolimus dose and serum trough levels for 6 patients. Initially, target serum drug levels were established and FSC optimization was performed whereby patient-specific therapeutic response constants, or indicators of how that specific patient's serum drug levels would respond to drug dosing, were determined. These constants were then utilized for subsequent dosing optimization.

RESULTS:

Patient tacrolimus dosages ranged from 0.5-2 mg, resulting in serum levels of 4.8-16.2 ng/ml. FSC stably converged into and stayed within the target tacrolimus range of 8-10 ng/ml at day 10, an improved response compared to a conventional regimen. Clinically-titrated and FSC-directed tacrolimus regimens were also compared. Of note, the FSC-optimized tacrolimus doses were different from those utilized clinically and were simultaneously capable of maintaining steady target serum levels over the entire course of treatment.

CONCLUSIONS:

FSC formulated patient-specific optimal tacrolimus dosing regimens with rapid convergence into a specified target serum tacrolimus range based only on previous doses and blood levels. Given the phenotypically-driven nature of FSC, this powerful platform can robustly achieve therapeutic levels of an immunosuppressive drug with unprecedented personalization.

REFERENCES

1. P.K. Wong, C.M. Ho, et al., PNAS, 2008

2. H. Tsutsui et al., Nat Comm, 2011.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Zarrinpar A, Silva A, Lee D-K, Datta N, Ho C-M, Ho D. Phenotypic Personalized Medicine: Mechanism-Independent Convergence Into Target Serum Tacrolimus Levels for Optimized Liver Transplant Immunosuppression [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/phenotypic-personalized-medicine-mechanism-independent-convergence-into-target-serum-tacrolimus-levels-for-optimized-liver-transplant-immunosuppression/. Accessed May 31, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences